Advice Pool - Finance

Just like with home mortgage loans, it is possible to fill joint applications on car loans and add up both incomes to meet the requirement

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

s for approval.

There are however things that need to be taken into consideration. All depends on the lender but there are additional req

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

irements that you’ll need to meet in order to obtain finance this way. Income and credit requirements may increase a bit and then of cours

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

, there is the problem of the vehicle’s property which may be required to be shared by the car loan applicants.

Joint Application Is

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ot Only Co-signing

This is an important difference to be made. When you co-sign a loan contract, the co-signer is obliged to repayin

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

g the loan, just like the main borrower. If the borrower for any circumstances can’t repay the loan, the co-signer has to take his place o

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

else he would be liable. However, the co-signer doesn’t necessary have anything to do with the property purchased or used as collateral.

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

Joint application implies that both parties will be owners of the vehicle and thus, protected by the insurance and all the legal consequen

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

es associated with the right of property. Thus, though joint application implies the co-signature of the loan contract, co-signing doesn’t

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

imply the right of property of the vehicle and thus, is not the same as a joint application.

The Insurance Issue And Car Ownership <

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

b>

Joint applications imply that the borrowers will be jointly purchasing the car with the money obtained from the car loan. This require

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

a lot of confidence because a co-ownership has many consequences. To third parties, both owners are equally responsible for any damage an

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

thus, will have to respond with their assets if anything happens.

Insurance however, will cover both parties. The only problem is that t

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

he insurance premium will only be as low as the higher insurance premium if both applicants would have to be considered separately. This i

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

plies significant loses for the less risky one of the co-signers. Thus, when it is an option, deciding whether co-signing or applying join

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ly needs to be well thought.

Co-Sign or Apply Jointly?

This question will depend on whether there is a lot of confidence or no

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

between the applicants. Many suggest that if you are planning to help someone purchase a car that you insist on joint application because

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

if he fails to pay the monthly payments you can always force the sell of the vehicle to cancel your debt. However, you need to consider a

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

so the consequences of owning a vehicle that you can’t control all the time. If an accident happens and insurance doesn’t cover it, as an

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

wner of the vehicle, you’ll also be held responsible. That won’t be a problem if you just co-signed the loan. Thus, it is really up to you

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Advice Pool - Joint Application On Car Loans?

Related Articles: